Literature DB >> 10580361

Peripheral arterial involvement in neurofibromatosis type 1--a case report.

E T Ilgit1, M Vural, A Oguz, M E Ozdogan.   

Abstract

Neurofibromatosis is a dominantly inherited, progressive, generalized dysplasia of mesodermal and neuroectodermal tissues. Vascular lesions associated with neurofibromatosis type 1 (NF-1) are mainly characterized by stenosis, occlusion, aneurysm, pseudoaneurysm, and rupture or fistula formation of small, medium, and large-sized arteries. The authors hereby present a rare case of NF-1 with bilateral aneurysms and large pseudoaneurysms of the femoral and popliteal arteries and occlusion of the left superficial femoral artery.

Entities:  

Mesh:

Year:  1999        PMID: 10580361     DOI: 10.1177/000331979905001111

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

1.  Ruptured profunda femoris aneurysm secondary to neurofibromatosis: vascular involvement in an unusual location.

Authors:  Bilgin Emrecan; Gokhan Onem; Ibrahim Susam
Journal:  Tex Heart Inst J       Date:  2010

2.  Dissection and rupture of the left subclavian artery presenting as hemothorax in a patient with von Recklinghausen's disease.

Authors:  Kazunori Yoshida; Satoshi Tobe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-02

3.  Neurofibromatosis 1 vasculopathy manifesting as a peripheral aneurysm in an adolescent.

Authors:  Shannon G Farmakis; Min Han; Frances White; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2014-04-27

4.  Spontaneous Renal Artery Dissection in a Patient with Neurofibromatosis Type I.

Authors:  Nicolas W Shammas; Majid Z Chammas; Jon Robken; Edmund Coyne
Journal:  Case Rep Cardiol       Date:  2016-10-27

Review 5.  Neurofibromatosis type 1-associated multiple rectal neuroendocrine tumors: A case report and review of the literature.

Authors:  Rui Xie; Kuang-I Fu; Shao-Min Chen; Bi-Guang Tuo; Hui-Chao Wu
Journal:  World J Gastroenterol       Date:  2018-09-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.